4OIO

Crystal structure of Thermus thermophilus pre-insertion substrate complex for de novo transcription initiation

4OIO の概要

• エントリーDOI: 10.2210/pdb4oio/pdb
• 関連するPDBエントリー: 4OIN 4OIP 4OIQ 4OIR
• 分子名称: DNA-directed RNA polymerase subunit alpha, ADENOSINE-5'-TRIPHOSPHATE, 5'-O-[(S)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]methyl}phosphoryl]cytidine, ... (12 entities in total)
• 機能のキーワード: de novo transcription initiation, substrate complex, transcription initiation, i site, i+1 site, rna polymerase, dna/rna/ntp binding, polymerization of ribonucleotides, nucleoid, transcription, transferase
• 由来する生物種: Thermus thermophilus; 詳細
• 細胞内の位置: Cytoplasm (By similarity): Q5SKW1
• タンパク質・核酸の鎖数: 8
• 化学式量合計: 444918.37

構造登録者

Zhang, Y.,Ebright, R.H.,Arnold, E. (登録日: 2014-01-20, 公開日: 2014-05-07, 最終更新日: 2023-09-20)

主引用文献

Zhang, Y.,Degen, D.,Ho, M.X.,Sineva, E.,Ebright, K.Y.,Ebright, Y.W.,Mekler, V.,Vahedian-Movahed, H.,Feng, Y.,Yin, R.,Tuske, S.,Irschik, H.,Jansen, R.,Maffioli, S.,Donadio, S.,Arnold, E.,Ebright, R.H.
GE23077 binds to the RNA polymerase 'i' and 'i+1' sites and prevents the binding of initiating nucleotides.
Elife, 3:e02450-e02450, 2014

PubMed Abstract: Using a combination of genetic, biochemical, and structural approaches, we show that the cyclic-peptide antibiotic GE23077 (GE) binds directly to the bacterial RNA polymerase (RNAP) active-center 'i' and 'i+1' nucleotide binding sites, preventing the binding of initiating nucleotides, and thereby preventing transcription initiation. The target-based resistance spectrum for GE is unusually small, reflecting the fact that the GE binding site on RNAP includes residues of the RNAP active center that cannot be substituted without loss of RNAP activity. The GE binding site on RNAP is different from the rifamycin binding site. Accordingly, GE and rifamycins do not exhibit cross-resistance, and GE and a rifamycin can bind simultaneously to RNAP. The GE binding site on RNAP is immediately adjacent to the rifamycin binding site. Accordingly, covalent linkage of GE to a rifamycin provides a bipartite inhibitor having very high potency and very low susceptibility to target-based resistance. DOI: http://dx.doi.org/10.7554/eLife.02450.001.

PubMed: 24755292

実験手法

X-RAY DIFFRACTION (3.1 Å)